Abeona Therapeutics
ABEO
127 hedge funds and large institutions have $243M invested in Abeona Therapeutics in 2026 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 43 increasing their positions, 32 reducing their positions, and 12 closing their positions.
167% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 12
104% more call options, than puts
Call options by funds: $9.65M | Put options by funds: $4.74M
37% more capital invested
Capital invested by funds: $177M → $243M (+$66.2M)
34% more repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 32
18% more funds holding
Funds holding: 108 → 127 (+19)
0.18% less ownership
Funds ownership: 69.3% → 69.12% (-0.18%)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OIA
OneDigital Investment Advisors
Overland Park,
Kansas
|
+$9.08M |
| 2 |
AIC
AWM Investment Company
New York
|
+$3.75M |
| 3 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$3.34M |
| 4 |
Tudor Investment Corp
Stamford,
Connecticut
|
+$1.98M |
| 5 |
Barclays
London,
United Kingdom
|
+$1.81M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Suvretta Capital Management
New York
|
-$11.9M |
| 2 |
6CM
683 Capital Management
New York
|
-$3.45M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
-$2.64M |
| 4 |
PBM
Propel Bio Management
Los Angeles,
California
|
-$1.9M |
| 5 |
TCM
Tang Capital Management
San Diego,
California
|
-$1.79M |
ABEO Hedge Fund Activity: Q2 2026 in Review
127 of the 8,305 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics (ABEO) for Q2 2026, worth a combined $243M — up 37% from $177M a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new ABEO positions and 12 closed out — a net gain of 20 holders — while 43 added to existing stakes and 32 trimmed.
The largest buyer was OneDigital Investment Advisors, opening a new position worth an estimated $9.08M. The largest seller was Suvretta Capital Management, cutting an estimated $11.9M.
- 127 institutional investors held Abeona Therapeutics (ABEO) as of Q2 2026, up from 108 in Q1 2026.
- Funds reported $243M of Abeona Therapeutics stock for Q2 2026, up 37% quarter-over-quarter.
- 32 funds opened new Abeona Therapeutics positions in Q2 2026 and 12 closed out, a net change of +20 holders.
- The largest Abeona Therapeutics buyer in Q2 2026 was OneDigital Investment Advisors, an estimated $9.08M added.
- The largest Abeona Therapeutics seller in Q2 2026 was Suvretta Capital Management, an estimated $11.9M sold.
Based on aggregated 13F filings for Q2 2026.